Results 111 to 120 of about 20,432 (139)

Determinants and outcomes of adverse drug reactions among people living with HIV on antiretroviral therapy in Nigeria. [PDF]

BMC Infect Dis
Etuk VP, Adeoye IA, Salawu MM, Fawole OI.   +3 more
europepmc   +1 more source

Treatment failure in adolescents and young people living with HIV: a cohort study. [PDF]

Rev Bras Enferm
Piran CMG, Cargnin AVE, Mori MM, Silva MD, Marcon SS, Higarashi IH, Frade JMG, Furtado MD.   +7 more
europepmc   +1 more source

Efavirenz-Induced Hepatitis Mimicking Autoimmune Hepatitis: A Case Report. [PDF]

Cureus
Chowdhury AH, Chowdhury D, Jahan I, Woghiren A, Saleh M.   +4 more
europepmc   +1 more source

Determinants of HIV-1 virologic suppression in HIV-associated tuberculosis in Brazil. [PDF]

Mem Inst Oswaldo Cruz
Ridolfi F, Amorim G, Haas DW, Arriaga M, Staats C, Cordeiro-Santos M, Kritski AL, Figueiredo MC, Andrade BB, Sterling TR, Rolla VC, Regional Prospective Observational Research in Tuberculosis (RePORT)-Brazil Consortium, Benjamin A, Sant'Anna FM, Oliveira JG, Marin J, Rezende A, Carvalho AC, Rocha M, Nogueira B, Brito A, Spener R, Turner M.   +22 more
europepmc   +1 more source

Effect of transitioning virally suppressed children and adolescents with HIV to dolutegravir-based antiretroviral therapy: emulated target trials in a large cohort in South Africa

Brown JA, Sookrajh Y, Mtila L, Lushaba N, Hlabisa M, van der Molen JS, Tlhaku K, Nkosi M, Ngwenya T, Khubone T, Mahomed S, Chammartin F, Archary M, Garrett N, Lewis L, Dorward J.   +15 more
europepmc   +1 more source

Timely updates to the Summary of Product Characteristics: supporting evidence-based prescribing in pregnancy. [PDF]

Front Glob Womens Health
Rasi V, Cortina-Borja M, Sconza R, Thorne C.   +3 more
europepmc   +1 more source

Brain Structure of South African Children Born to Mothers on Dolutegravir Versus Efavirenz-Based Antiretroviral Therapy. [PDF]

J Pediatric Infect Dis Soc
Bradford LE, Wedderburn CJ, Malaba TR, Theunissen H, Ringshaw JE, Bourke NJ, Williams SCR, He N, Read L, Waitt C, Reynolds H, Colbers A, Read J, Davel L, Orrell C, Taegtmeyer M, Wang D, Khoo S, Myer L, Donald KA.   +19 more
europepmc   +1 more source

Temporal shifts in antiretroviral therapy regimens and metabolic outcomes in people living with HIV: A systematic review and meta-analysis. [PDF]

HIV Med
Mahanani MR, Chit M, Mohr S, Cama I Gibernau E, Hetjens S, Winkler V, Steffen HM, Neuhann F.   +7 more
europepmc   +1 more source

Cost-effectiveness of efavirenz 600 mg vs . 400 mg in people living with HIV in China. [PDF]

Chin Med J (Engl)
Wang Z, Qi H, Gao M, Hu J, Song X, Lyu W, Cao W, Zhao X, Zhao F, Li T.   +9 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Efavirenz: History, Development and Future

Biomolecules, 2023
Nuno Vale, Barbara Costa
exaly